* future needs for radiopharmaceutical development for the diagnosis and treatment of human disease,
* future needs for computational and instrument development for more precise localization of radiotracers in normal and aberrant cell physiologies,
* national impediments to the efficient entry of promising new radiopharmaceutical compounds into clinical feasibility studies and strategies to overcome them and
* impacts of shortages of isotopes and highly trained radiochemists on nuclear medicine research, and short- and long-term strategies to alleviate these shortages if they exist.


Other SNM members on the NAS committee include Joanna S. Fowler, a senior chemist at Brookhaven National Laboratory and director of the Brookhaven PET Program, Upton, N.Y.; S. James Adelstein, Paul C. Cabot Distinguished Professor of Medical Biophysics at Harvard Medical School, Boston, Mass.; Joel Karp, chief of the physics and instrumentation research section in the Department of Radiology and director of the Department of Radiology PET Center at the University of Pennsylvania, Philadelphia, Pa.; Thomas Lewellen, professor of radiology, adjunct professor of electrical engineering, and director of physics and instrumentation development in nuclear medicine at the University of Washington, Seattle; C. Douglas Maynard*, former chair of the radiology department and currently professor emeritus of radiology at Wake Forest University School of Medicine, Winston-Salem, N.C.; Marcus E. Raichle, professor of radiology, neurology, neurobiology, biomedical engineering and psychology and co-director of the Division of Radiological Sciences in the Mallinckrodt Institute of Radiology at the Washington University School of Medicine, St. Louis, Mo.; Thomas J. Ruth, director of the PET Program at the University of British Columbia, Vancouver; and Heinrich Schelbert, professor of molecular and medical pharmacology at the University of California at Los Angeles and the George V. Taplin professor of nuclear medicine at the university's David Geffen School of Medicine and editor in chief of SNM's Journal of Nuclear Medicine.
Other committee members include Hedwig Hricak*, Memorial Sloan-Kettering Cancer Center, New York, N.Y.; Joe Gray, associate laboratory director for life and environmental science at the Lawrence Berkeley National Laboratory, director of LBNL's life sciences division and adjunct professor of laboratory medicine and radiation oncology at the University of California at San Francisco; Lin-Wen Hu, associate director for research development and utilization at the Massachusetts Institute of Technology's Nuclear Reactor Laboratory, Cambridge, Mass.; Roger Macklis, professor of medicine at the Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio; Gustav Von Schulthess, professor of nuclear medicine at the University Hospital of Zurich, Switzerland; and Jacquelyn Yanch, professor of nuclear engineering at Massachusetts Institute of Technology, Cambridge, Mass.

More Industry Headlines